+ 1 888 391 5441

» Pharmaceuticals Subscribe

Pharmaceutical Industry Business Confidence Report H2 2016

Summary The existing economic environment is stable for the pharmaceutical industry, and customer confidence levels will remain constant in H2 2016 (July 2016-December 2016). Companies are slightly optimistic about economic conditions in North America and the Asia-Pacific due to positive momentum in the US, firm domestic demand, and strong government expenditure in India. The pharmaceutical industry is expected to record higher expenditure towards new product development and mergers and acquisitions in H2 2016 as compared to H1 2016. Moreover, executives with business operations in the Asia-Pacific... 

Top Trends in Healthcare and OTC; Exploring the over-the-counter medication; vitamins, minerals and supplements; functional food and drink; and sports nutrition categories

Summary The market for healthcare and OTC is primarily driven by the Health and Wellness megatrend, but manufacturers must look beyond health functionality alone to remain relevant in an ever-evolving category. Pharmaceutical, sports nutrition, and healthcare companies must draw on inspiration from the broader food and drink space to respond to trends such as “pill fatigue,” and a growing preference for “natural” healthcare solutions. Key Findings The pressures of busy modern lifestyles are taking their toll on consumers, with tiredness and stress being the most pressing... 

Pharmaceutical Industry Business Outlook and Procurement Report H1 2016

Summary The key priorities forecast in the business structure for global pharmaceutical industry executives in H1 2016 (April-September 2016) are new product development and improving operational efficiency. China, India, and Brazil are the leading emerging markets that are expected to offer the most opportunities for global pharmaceutical industry growth in H1 2016. Market uncertainty and rising competition are the immediate business concerns for global pharmaceutical industry executives. The gradual slowdown and restructuring of economic activity in China and tightening of the monetary policy... 

Pharmaceutical Industry Business Confidence Report H1 2016

Summary The existing economic environment is stable for the pharmaceutical industry, and customer confidence levels will remain constant in H1 2016 (January 2016-June 2016). Companies are slightly optimistic about economic conditions in North America and Asia-Pacific due to positive momentum in the US manufacturing and production sectors, firm domestic demand, strong government expenditure in India, and robust private consumption and export growth in South Korea and Vietnam. Over the next six months the industry will increase its expenditure towards new product development and IT infrastructure.... 

Dietary Supplements in an Age of Personalized Nutrition ; How the trend towards personalized health will impact the dietary supplements market

Summary The rise of personalized nutrition is providing fresh impetus and new opportunities within the market for dietary supplements. This report considers the evolving landscape of the supplements industry. Key Findings Personalized nutrition offers manufacturers the chance to develop an ongoing relationship with consumers rather than a single transactional approach. This benefits both suppliers, who can build a base of loyal customers, and consumers, who gain a personalized and dedicated service. Although the growth of the global market for vitamins, minerals, and supplements has slowed in... 

Pharmaceutical Industry Business Confidence Report H1 2015

Summary “Pharmaceutical Industry Business Confidence Report H1 2015” is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the pharmaceutical industry. This report also examines executive opinions with regards to the current and future state of the economy and its effect on the industry. It analyzes the likely effect of supplier price changes, sales performance, and staff headcount within the industry over January-June 2015. This report provides an overview of the key... 

Rx-OTC Switch Opportunities : Trends in OTC, category analysis, case studies and future opportunities

Summary After years of buoyant growth, the pharmaceutical industry is facing up to a more challenging time. With the growing cost of developing novel drugs, combined with rising regulatory pressures, the use of lifecycle management is playing an ever-more important role in the increasingly cost-conscious pharma industry. This report identifies actual opportunities in OTC switching. Key Findings The pharmaceutical market is changing. Since 2007, sales of OTC drugs have outstripped those for their prescription counterparts. Whereas once consumer health products were seen as a lucrative sideline,... 

Pharmaceutical Business Confidence Report Q4 2014

Summary “Pharmaceutical Business Confidence Report Q4 2014” is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the pharmaceutical industry over October-December 2014. This report also examines executive opinions with regards to the current and future state of the economy and its effect on the industry. It analyzes the likely effect of supplier price changes, sales performance, and staff headcount within the industry. Furthermore, this report provides an overview... 

Pharmaceutical Business Confidence Report Q3 2014

Summary “Pharmaceutical Business Confidence Report Q3 2014” is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the pharmaceutical industry. This report also examines executive opinion with regards to the current and future state of the economy and its retrospective effect on the industry. It analyzes the likely effect of supplier price changes, sales performance, and staff headcount within the industry over July–September 2014. In addition, it provides an overview... 

Pharmaceutical Business Confidence Report Q1 2014

Synopsis “Pharmaceutical Business Confidence Report Q1 2014” is a new report by Kable that analyzes pharmaceutical industry executives’ views on the global economy, expectations on customer confidence, supplier prices, key business concerns, and how executives’ future investments are set to change in Q1 2014. This report also gives you access to regional analysis of industry outlook, industry and company growth prospects, future opportunities, staff hiring, and sales performance. Apart from providing access to the opinions and strategies of global pharmaceutical industry... 
© 2017 · RSS